Australian Clinical Labs
ACL.AX
#6784
Rank
$0.46 B
Marketcap
$2.29
Share price
-1.12%
Change (1 day)
36.33%
Change (1 year)

Revenue for Australian Clinical Labs (ACL.AX)

Revenue in 2023: $0.45 Billion USD

According to Australian Clinical Labs's latest financial reports the company's current revenue (TTM ) is $0.45 Billion USD. In 2023 the company made a revenue of $0.45 Billion USD a decrease over the revenue in the year 2022 that were of $0.68 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Australian Clinical Labs from 2021 to 2023

Annual revenue

Year Revenue Change
2023$0.45 B-32.69%
2022$0.68 B41.26%
2021$0.48 B